These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 21272600

  • 21. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
    Jiang C, Jiang Y, Huang Z, Shen W, Wang J, Shen Q.
    Cancer Immunol Immunother; 2010 Dec; 59(12):1771-9. PubMed ID: 20809357
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inoculation of Lactobacillus expressing hCG beta in the vagina induces an anti-hCG beta antibody response in murine vaginal mucosa.
    Yao XY, Wang HM, Li DJ, Yuan MM, Wang XL, Yu M, Wang MY, Zhu Y, Meng Y.
    J Reprod Immunol; 2004 Oct; 63(2):111-22. PubMed ID: 15380942
    [Abstract] [Full Text] [Related]

  • 24. Human chorionic gonadotropin as a target for cancer vaccines.
    Triozzi PL, Stevens VC.
    Oncol Rep; 1999 Oct; 6(1):7-17. PubMed ID: 9864394
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in contraceptive vaccine development: a mini-review.
    Naz RK, Gupta SK, Gupta JC, Vyas HK, Talwar AG.
    Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
    [Abstract] [Full Text] [Related]

  • 26. Designing a new generation of anti-hCG vaccines for cancer therapy.
    Delves PJ, Iles RK, Roitt IM, Lund T.
    Mol Cell Endocrinol; 2007 Jan 02; 260-262():276-81. PubMed ID: 17049720
    [Abstract] [Full Text] [Related]

  • 27. Making of a vaccine preventing pregnancy without impairment of ovulation and derangement of menstrual regularity and bleeding profiles.
    Talwar GP.
    Contraception; 2013 Mar 02; 87(3):280-7. PubMed ID: 23040138
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
    Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR.
    Biol Reprod; 2003 Jul 02; 69(1):338-46. PubMed ID: 12672665
    [Abstract] [Full Text] [Related]

  • 29. A unique vaccine for control of fertility and therapy of advanced-stage terminal cancers ectopically expressing human chorionic gonadotropin.
    Talwar GP.
    Ann N Y Acad Sci; 2013 Apr 02; 1283():50-6. PubMed ID: 23302029
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin beta.
    Yu N, Xu W, Jiang Z, Cao Q, Chu Y, Xiong S.
    Immunol Lett; 2007 Dec 15; 114(2):94-102. PubMed ID: 17964664
    [Abstract] [Full Text] [Related]

  • 31. The human chorionic gonadotropin-beta arginine68 to glutamic acid substitution fixes the conformation of the C-terminal peptide.
    Charrel-Dennis M, Terrazzini N, McBride JD, Kaye P, Martensen PM, Justesen J, Berger P, Lapthorn A, Kelly C, Roitt IM, Delves PJ, Lund T.
    Mol Endocrinol; 2005 Jul 15; 19(7):1803-11. PubMed ID: 15718290
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 15; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 34. [Biosynthesis of a single peptide chain containing human chorionic gonadotropin beta and ovine common alpha subunits tandem].
    Xie L, Li CL, Shen H, Shen QX, Wang J.
    Shi Yan Sheng Wu Xue Bao; 1998 Mar 15; 31(1):61-8. PubMed ID: 12014113
    [Abstract] [Full Text] [Related]

  • 35. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
    Morse MA, Bradley DA, Keler T, Laliberte RJ, Green JA, Davis TA, Inman BA.
    Expert Rev Vaccines; 2011 Jun 15; 10(6):733-42. PubMed ID: 21692696
    [Abstract] [Full Text] [Related]

  • 36. [Expression of HCGbeta-CTP polymeride by the methylotropic yeast, pichia pastoris and structure prediction of the expressed products].
    Yu GR, Sun XZ, Shen WY, Hou LL, Feng WH, Jiang S, Shen QX.
    Shi Yan Sheng Wu Xue Bao; 2005 Apr 15; 38(2):157-63. PubMed ID: 16011249
    [Abstract] [Full Text] [Related]

  • 37. Non-cross-reactive monoclonal antibodies to human chorionic gonadotropin generated after immunization with a synthetic peptide.
    Caraux J, Chichehian B, Gestin C, Longhi B, Lee AC, Powell JE, Stevens VC, Pourquier A.
    J Immunol; 1985 Feb 15; 134(2):835-40. PubMed ID: 2578164
    [Abstract] [Full Text] [Related]

  • 38. Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits.
    Talwar GP, Gupta JC, Shankar NV.
    Am J Reprod Immunol; 2011 Jul 15; 66(1):26-39. PubMed ID: 21501278
    [Abstract] [Full Text] [Related]

  • 39. Relevance of immuno-contraceptive vaccines for population control. I. Hormonal immunocontraception.
    Gupta SK, Koothan PT.
    Arch Immunol Ther Exp (Warsz); 1990 Jul 15; 38(1-2):47-60. PubMed ID: 2126920
    [Abstract] [Full Text] [Related]

  • 40. Immuno-contraception undergoing promising trials.
    Koshy LM.
    Indian Med Trib; 1994 Aug 15; 2(13):7. PubMed ID: 12179186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.